Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other Diseases) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) Analysis, Share, Trends, Size, & Forecast From 2016 2027- COVID- 19 Updated
- Published Date: 2020-10-13
- Report ID: 1782
- Pages: 230
-
Format:
REPORT HIGHLIGHT
The Global Biosimilars Market- Industry Analysis, Share, Trend, Market Size and Forecast was estimated to be around US$ 11.69 billion in 2019 and is anticipated to grow with 26.9% of growth rate during the future period.
This report segments the global Biosimilars Market by product type, application and geography. Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. When the patent of branded drug is expired, pharmaceutical companies are planning to develop off-patent biologics i.e. biosimilars that offer similar biological activity. The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of pharmaceutical drugs.
COVID-19's Multifaceted Impact on Biosimilars Industry
As the COVID-19 pandemic spreads, this will continue to affect the global biopharmaceutical industry. Biosimilars are no exception, and the impact on its demand and adoption will be multifaceted. The propose report discuss three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.
In terms of product types, the market for recombinant glycosylated proteins continue to dominate during the forecast period, while the market for recombinant non-glycosylated proteins biosimilars will see a huge potential during the forecast period. On other side, oncology was the largest application segment in 2016, and expected to be the fastest growing application segment in the forecast period.
Companies reported in this report are: Amgen, Inc, AstraZeneca, Pfizer, Inc., BIOCON Limited, Novartis AG, STADA, Teva Pharmaceuticals Inc. and Others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.
The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.
The years considered for the study are:
Historical Year 2016 to 2018
Base Year 2019
Estimated Year 2020
Projected Year 2027
The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.
The research report categorizes the Biosimilars Market in each of the following submarkets to forecast the revenues and analyze the trends:
GLOBAL BIOSIMILARS MARKET, BY PRODUCT TYPES
Recombinant Glycosylated Proteins
Recombinant Non-Glycosylated Proteins
Recombinant Peptides
GLOBAL BIOSIMILARS MARKET, BY APPLICATION
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Others
GLOBAL BIOSIMILARS MARKET, BY REGION
North America
Europe
Asia Pacific
Rest of the World
TABLE OF CONTENT
BIOSIMILARS MARKET OVERVIEW
Study Scope
Base Year
Assumption and Methodology
EXECUTIVE SUMMARY
Key Market Facts
Geographical Scenario
Companies in the Market
BIOSIMILARS MARKETKEY MARKET TRENDS
Market Drivers
Impact Analysis of Market Drivers
Market Restraints
Impact Analysis of Market Restraints
Market Opportunities
Market Future Trends
BIOSIMILARS MARKETINDUSTRY STUDY
Pipeline Therapeutic Analysis
Pricing Analysis
New Introduction by Leading Companies
BIOSIMILARS MARKET LANDSCAPE
Market Share Analysis
Key Innovators
BIOSIMILARS MARKET BY PRODUCT TYPES:
Overview
Recombinant Glycosylated Proteins
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Recombinant Non-Glycosylated Proteins
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Recombinant Peptides
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
BIOSIMILARS MARKET BY APPLICATION:
Overview
Oncology
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Blood Disorders
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Infectious Diseases
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Autoimmune Diseases
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Other Diseases
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
BIOSIMILARS MARKET BY GEOGRAPHY
Introduction
North America
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
U.S.
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Canada
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
France
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Germany
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Asia Pacific (APAC)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
China
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
India
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of APAC
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of the World
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Latin America
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Middle East and Africa
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
KEY VENDOR ANALYSIS
Astra Zeneca, plc
Company Overview
SWOT Analysis
Key Developments
Amgen, Inc.
Company Overview
SWOT Analysis
Key Developments
Pfizer, Inc.
Company Overview
SWOT Analysis
Key Developments
Biocon Ltd.
Company Overview
SWOT Analysis
Key Developments
Novartis AG
Company Overview
SWOT Analysis
Key Developments
Teva Pharma
Company Overview
SWOT Analysis
Key Developments
STADA AG
Company Overview
SWOT Analysis
Key Developments
360 DEGREE ANALYSTVIEW
APPENDIX
Research Methodology
Abbreviations
Disclaimer
Contact Us
SCOPE AND OBJECTIVES
The objective of this report is to describe the market trends and revenue forecasts for the Biosimilars Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the Biosimilars Market by its major segments, which include the type, end user industry, and the major geographic regions.
KEY BENEFITS OF THE REPORT:
Understanding of the strategies that are being adopted by the key players in this market to stay competitive
Extensive analysis of the key players dominating the competitive landscape of this market
In-depth analysis of the key factors are propelling the growth of the global market
Detailed analysis of the geographic region that will witness the strongest growth
Granular analysis of the current market scenario and the expected market grow
KEY PREMIUM INSIGHTS:
Rising consumer wealth and income levels, increasing government and patient awareness, and a trend towards healthier lifestyles are anticipated to boost health care spending to around 8.1% in 2014-2018 in Asia Pacific
Biosimilars require high costs of investment and require a time frame to 7-8 years to enter the market
Economic expansion and government focus on broader welfare policies will drive the market for biosimilars.
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
